|
|
|
Volumn 8, Issue 7, 2002, Pages 2233-2239
|
|
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: Identification of an endocrine-sensitive subgroup
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AROMATASE INHIBITOR;
CA 125 ANTIGEN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ESTROGEN RECEPTOR;
HEAT SHOCK PROTEIN 27;
LETROZOLE;
ONCOPROTEIN;
PROGESTERONE RECEPTOR;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
NITRILE;
TRIAZOLE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
GENE EXPRESSION;
HORMONE SENSITIVITY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
NAUSEA;
OVARY CANCER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
TUMOR GROWTH;
DISEASE COURSE;
ENZYME IMMUNOASSAY;
METABOLISM;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
OVARY TUMOR;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
AROMATASE;
CA-125 ANTIGEN;
DISEASE PROGRESSION;
ENZYME INHIBITORS;
FEMALE;
HUMAN;
IMMUNOENZYME TECHNIQUES;
MIDDLE AGE;
NITRILES;
OVARIAN NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
SUPPORT, NON-U.S. GOV'T;
TRIAZOLES;
AROMATASE INHIBITORS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035992369
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (145)
|
|
References (27)
|
